These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART. Karmakar S; Sharma SK; Vashishtha R; Sharma A; Ranjan S; Gupta D; Sreenivas V; Sinha S; Biswas A; Gulati V Clin Dev Immunol; 2011; 2011():239021. PubMed ID: 21197457 [TBL] [Abstract][Full Text] [Related]
11. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study. Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566 [TBL] [Abstract][Full Text] [Related]
12. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in initiating ART among HIV-Infected patients in China-risk factors and management. Yang H; Liu Q; Wu Y; He K; Zeng Q; Liu M BMC Infect Dis; 2024 Jan; 24(1):5. PubMed ID: 38166781 [TBL] [Abstract][Full Text] [Related]
13. Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis. Namale PE; Abdullahi LH; Fine S; Kamkuemah M; Wilkinson RJ; Meintjes G Future Microbiol; 2015; 10(6):1077-99. PubMed ID: 26059627 [TBL] [Abstract][Full Text] [Related]
14. Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial). Stek C; Schutz C; Blumenthal L; Thienemann F; Buyze J; Nöstlinger C; Ravinetto R; Wouters E; Colebunders R; Maartens G; Wilkinson RJ; Lynen L; Meintjes G JMIR Res Protoc; 2016 Aug; 5(3):e173. PubMed ID: 27571786 [TBL] [Abstract][Full Text] [Related]
15. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS. Meintjes G; Stek C; Blumenthal L; Thienemann F; Schutz C; Buyze J; Ravinetto R; van Loen H; Nair A; Jackson A; Colebunders R; Maartens G; Wilkinson RJ; Lynen L; N Engl J Med; 2018 Nov; 379(20):1915-1925. PubMed ID: 30428290 [TBL] [Abstract][Full Text] [Related]
16. TB-IRIS pathogenesis and new strategies for intervention: Insights from related inflammatory disorders. Cevaal PM; Bekker LG; Hermans S Tuberculosis (Edinb); 2019 Sep; 118():101863. PubMed ID: 31561185 [TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution inflammatory syndrome in HIV-infected patients with tuberculosis. Kiertiburanakul S J Med Assoc Thai; 2010 Feb; 93(2):257-64. PubMed ID: 20302011 [TBL] [Abstract][Full Text] [Related]
18. A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition. Sharma SK; Dhooria S; Barwad P; Kadhiravan T; Ranjan S; Miglani S; Gupta D Indian J Med Res; 2010 Jun; 131():804-8. PubMed ID: 20571170 [TBL] [Abstract][Full Text] [Related]
19. The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome. Lai RP; Nakiwala JK; Meintjes G; Wilkinson RJ Eur J Immunol; 2013 Aug; 43(8):1995-2002. PubMed ID: 23928963 [TBL] [Abstract][Full Text] [Related]
20. Management of the immune reconstitution inflammatory syndrome. Meintjes G; Scriven J; Marais S Curr HIV/AIDS Rep; 2012 Sep; 9(3):238-50. PubMed ID: 22752438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]